GL1X · GenesisL1 explorer

MolNFT v1 · #102205 · protein

Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors

4OEW · Cgmp-specific 3',5'-cyclic phosphodiesterase: “Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors”. X-ray diffraction, 3 ligands (5IO, ZN, MG), 2 pockets (best druggability 0.65). MolNFT v1 #102205 on…

PDB
4OEW
Type
protein
Length
289 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cgmp-specific 3',5'-cyclic phosphodiesterase
EC
3.1.4.35
UniProt
O76074
Ligands
5IO, ZN, MG
Pockets
2 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 70% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACgmp-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35)protein28970% helix, 0% strandO76074

Ligands and binding sites

  • 5IO · 6-ethyl-5-iodo-2-{5-[(4-methylpiperazin-1-yl)sulfonyl]-2-propoxyphenyl}pyrimidin-4(3H)-one · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13010.650.8136MG, 5IO
2740.440.8123empty

Compared structures

  • 4OEW · Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors · the same entry in another collection · chain A against A, TM-score 1.00
  • O76074 · AlphaFold monomer V2.0 prediction for cgmp-specific 3',5'-cyclic phosphodiesterase… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.